Clinical Guidance for the Management of Patients with Urothelial Cancers During the COVID-19 Pandemic - Rapid Review.
Clin Oncol (R Coll Radiol)
; 32(6): 347-353, 2020 06.
Article
in English
| MEDLINE | ID: covidwho-116897
ABSTRACT
The current COVID-19 pandemic presents a substantial obstacle to cancer patient care. Data from China as well as risk models suppose that cancer patients, particularly those on active, immunosuppressive therapies are at higher risks of severe infection from the illness. In addition, staff illness and restructuring of services to deal with the crisis will inevitably place treatment capacities under significant strain. These guidelines aim to expand on those provided by NHS England regarding cancer care during the coronavirus pandemic by examining the known literature and provide guidance in managing patients with urothelial and rarer urinary tract cancers. In particular, they address the estimated risk and benefits of standard treatments and consider the alternatives in the current situation. As a result, it is recommended that this guidance will help form a framework for shared decision making with patients. Moreover, they do not advise a one-size-fits-all approach but recommend continual assessment of the situation with discussion within and between centres.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Pneumonia, Viral
/
Urologic Neoplasms
/
Immunocompromised Host
/
Coronavirus Infections
/
Betacoronavirus
Type of study:
Observational study
/
Prognostic study
/
Reviews
Limits:
Humans
Country/Region as subject:
Europa
Language:
English
Journal:
Clin Oncol (R Coll Radiol)
Journal subject:
Neoplasms
Year:
2020
Document Type:
Article
Affiliation country:
J.clon.2020.04.005
Similar
MEDLINE
...
LILACS
LIS